Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer
Clinical trial NCT06564870 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06564870
- Sponsor
- University Hospital, Brest
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.